1. Home
  2. PTCT vs ACLS Comparison

PTCT vs ACLS Comparison

Compare PTCT & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$82.28

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$145.42

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
ACLS
Founded
1998
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.8B
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
PTCT
ACLS
Price
$82.28
$145.42
Analyst Decision
Buy
Buy
Analyst Count
17
4
Target Price
$80.65
$101.50
AVG Volume (30 Days)
2.2M
660.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
N/A
EPS
N/A
0.30
Revenue
$264,734,000.00
$839,048,000.00
Revenue This Year
N/A
$1.93
Revenue Next Year
$17.70
$7.91
P/E Ratio
N/A
$481.00
Revenue Growth
36.19
N/A
52 Week Low
$43.18
$65.64
52 Week High
$87.50
$193.78

Technical Indicators

Market Signals
Indicator
PTCT
ACLS
Relative Strength Index (RSI) 65.15 40.90
Support Level $73.41 $137.70
Resistance Level $87.27 $147.94
Average True Range (ATR) 3.11 12.40
MACD 0.22 -2.86
Stochastic Oscillator 75.57 5.43

Price Performance

Historical Comparison
PTCT
ACLS

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

Share on Social Networks: